Penumbra Inc (PEN)

Industry Medical Devices


This stock can be held in an Investment ISA and an Investment Account
Sell

$259.50

Buy

$301.09

arrow-up$1.38 (+0.53%)

Prices updated at 17 Jan 2025, 21:55 EST
| Prices minimum 15 mins delay
|
Prices in USD

Penumbra Inc designs, develops, manufactures and markets medical devices. The products of the company address ischemic stroke, hemorrhagic stroke and vascular conditions that can be treated through thrombectomy and embolization procedures.

Income statement

20222023
847m1,059m
535m683m
6m92m
0.728.67
-2m91m
30m109m
Sales, General and administrative450m506m
Interest expenses2m2m
Provision for income taxes6m-11m
Operating expenses529m591m
Income before taxes4m80m
Net income available to common shareholders-2m91m
-0.052.37
Net interest income137,0005m
Advertising and promotion--
Net investment income, net--
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)-0.052.32
Free cash flow per share-2.36961.2155
Book value/share25.552428.5443
Debt equity ratio0.2240760.187379

Balance sheet

20222023
Current assets756m915m
Current liabilities145m151m
Total capital999m1,179m
Total debt236m234m
Total equity999m1,179m
Total non current liabilities--
Loans--
Total assets1,371m1,556m
Total liabilities--
Cash and cash equivalents70m167m
Common stock38m39m

Cash flow

20222023
Cash at beginning of period59m70m
Cash dividends paid--
-75m82m
Investments (gains) losses55m-16m
70m167m
Net income--
-56m97m
-19m-15m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Please note the value of investments can go down as well as up so you may get back less than you invested. This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to an authorised financial adviser. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and(3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.